Scientific Program

Preliminary Program
Theme: "CONTROVERSIES IN CANCER PAIN"

This two-day Satellite Symposium sponsored by the Australasian Chapter of Palliative Medicine and the Royal Australasian College of Physicians will present the following topics:

Traditional Controversies

Pharmacologic Issues

Medical Social and Moral Issues

From Bench to the Bedside

Dealing With Oploid Toxicity

Winding Down a Sensitized System: New Approaches to Pain Management

Contemporary Clinical Controversies in Cancer Pain

Day one: Traditional controversies

Thursday, 18 August 2005

Session 1: Introduction

08:00 - 08:45	Registration
08:45 - 09:00	Introduction and welcome P. Glare, Australia
09:00 - 09:30	Controversies in cancer pain: 1989-2005 K. Foley, USA

Session 2: Pharmacologic issues I

09:30 - 10:00	What is the "best" drug?, What method of administration is safe?, Is the WHO ladder obsolete? *P. Glare, Australia*
10:00 - 10:30	What is the appropriate route of administration? (incl. Spinal opioids), *E. Obbens, USA*
10:30 - 10:50	Discussion
10:50 - 11:20	Morning Tea

Session 3: Pharmacologic issues II

11:20 - 11:50	What Opioid receptors are important? *T. Vanderah, USA*
11:50 - 12:20	How is morphine (& other opioids) metabolised? *J. Hardy, Australia*
12:20 - 12:45	Discussion
12:45 - 14:00	Lunch

Session 4: Medical social and moral issues I: Barriers to cancer pain relief

14:00 - 14:30	Is tolerance a problem? What is the risk of addiction? *J. Ballantyn, USA*
14:30 - 14:50	Patient related Barriers to cancer pain relief, *M. Lovell, Australia*
14:50 - 15:10	Who will pay for high technology pain management? *E. Obbens, USA* WHO Policy, *K. Foley, USA*
15:10 - 15:30	Discussion
15:30 - 16:00	Afternoon Tea

Session 5: Medical social and moral issues II: Ethical controversies

16:00 - 16:20	Is cancer pain relief a form of euthanasia? *M. Ashby, Australia*
16:20 - 16:40	Is cancer pain relief a basic human right? *F. Brennan, Australia*
16:40 - 17:00	Discussion
19:00	Symposium BBQ Dinner (optional)

Day two: Emerging controversies in cancer pain

Friday, 19 August 2005

Session 1: From the bench to the bedside

09:00 - 09:30	Are pharmacogenomics relevant in this population? *A. Somogyi, Australia*
09:30 - 10:00	How to measure and analyse cancer pain: 1. In research 2. In the clinic *S. Kaasa, Norway*
10:00 - 10:30	Discussion
10:30 - 11:00	Morning Tea
11:00 - 11:30	Cancer pain staging systems, *S. Eychmueller, Switzerland*
11:30 - 12:00	Getting research into practice: EBM, guidelines and cancer pain relief, *D. Currow, USA*
12:00 - 12:30	Panel discussion: Why is there a gap between preclinical and clinical? Speakers and T. Vanderah, M. Lovell, K. Foley, E. Obbens
12:30 - 13:30	Lunch

Session 2: Dealing with opiod toxicity

13:30 - 13:50	Options for management of side effects
13:50 - 14:20	Opioid rotation, J. Hardy, Australia
14:20 - 14:30	Discussion

Session 3: Contemporary clinical controversies in cancer pain

14:30 - 15:00	Winding down a sensitized system: NMDA antagonists and other new approaches to cancer pain management, *M. Ashby, Australia*
15:00 - 15:30	Afternoon Tea
15:30 - 15:50	Controversies in Bone metastases: - which NSAID? - RT: one fraction or 10? - Biosphosphonates: should they be in the water supply? *B. Stafford, Australia*
15:50 - 16:10	Cannabinoids and cancer pain, *D. Kapur, Australia*
16:10 - 16:30	Discussion
16:30 - 16:45	Summary and Close, *P. Glare, Australia*

Download Program

Click here to download the current program.

Download Program (PDF 20Kb)

If you do not have Acrobat Reader, click below to get your free software that lets you view and print Adobe Portable Document Format (PDF) files.

Language

The official language of the Symposium is English.

Call for Abstracts

Please contact the chair for further information.

Clinical Associate Professor Paul Glare
Head Palliative Care
Sydney Cancer Centre
Royal Prince Alfred Hospital
Missenden Road
Camperdown, NSW 2050, AUSTRALIA
Tel: +61-2-9515-7755
Fax: +61-2-9515-7464
Email: paul@email.cs.nsw.gov.au